Company intelligence / Profile preview
Radiant Biotherapeutics
West Chester, Pennsylvania, United Statesradiantbio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Radiant is developing its lead clinical candidate 4-1BB, which is currently in pre-clinical stage. Their Multabody platform has demonstrated superior potency compared to traditional antibodies, with the ability to go from concept to in vivo proof of concept within six months[4].
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Antibody therapeuticsMulti-valent and multi-specific biologics
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
GSKRegeneron PharmaceuticalsBill & Melinda Gates Foundation
Beyond the preview
Go deeper on Radiant Biotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Radiant Biotherapeutics.